|
1
|
Increased particulate air pollution and the triggering of myocardial infarction.
|
Circulation
|
2001
|
6.94
|
|
2
|
Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. Determinants of Myocardial Infarction Onset Study Investigators.
|
N Engl J Med
|
1993
|
6.72
|
|
3
|
Circadian variation in the frequency of onset of acute myocardial infarction.
|
N Engl J Med
|
1985
|
5.09
|
|
4
|
Triggering of acute myocardial infarction onset by episodes of anger. Determinants of Myocardial Infarction Onset Study Investigators.
|
Circulation
|
1995
|
5.06
|
|
5
|
Circadian variation in the frequency of sudden cardiac death.
|
Circulation
|
1987
|
3.98
|
|
6
|
Morning increase in onset of ischemic stroke.
|
Stroke
|
1989
|
3.52
|
|
7
|
Triggering myocardial infarction by marijuana.
|
Circulation
|
2001
|
3.36
|
|
8
|
Triggering of myocardial infarction by cocaine.
|
Circulation
|
1999
|
3.06
|
|
9
|
Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death.
|
N Engl J Med
|
1987
|
2.83
|
|
10
|
Cholecystokinin and its COOH-terminal octapeptide in the pig brain.
|
Proc Natl Acad Sci U S A
|
1977
|
2.62
|
|
11
|
Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women.
|
J Am Coll Cardiol
|
1987
|
2.27
|
|
12
|
Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications.
|
Ann Intern Med
|
1980
|
2.19
|
|
13
|
Electrocardiographic and clinical criteria for recognition of acute myocardial infarction based on analysis of 3,697 patients.
|
Am J Cardiol
|
1983
|
2.18
|
|
14
|
Calcium channel blocking agents in the treatment of cardiovascular disorders. Part I: Basic and clinical electrophysiologic effects.
|
Ann Intern Med
|
1980
|
2.08
|
|
15
|
Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population.
|
Am J Cardiol
|
1987
|
2.01
|
|
16
|
Digoxin therapy and mortality after myocardial infarction. Experience in the MILIS Study.
|
N Engl J Med
|
1986
|
1.96
|
|
17
|
The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group.
|
J Am Coll Cardiol
|
1989
|
1.80
|
|
18
|
Association of blood pressure with fibrinolytic potential in the Framingham offspring population.
|
Circulation
|
2000
|
1.70
|
|
19
|
Electrocardiographic diagnosis of myocardial infarction in the presence of complete left bundle branch block.
|
Am Heart J
|
1988
|
1.69
|
|
20
|
Analysis of possible triggers of acute myocardial infarction (the MILIS study).
|
Am J Cardiol
|
1990
|
1.68
|
|
21
|
Comparison of long-term outcome after acute myocardial infarction in patients never graduated from high school with that in more educated patients. Multicenter Investigation of the Limitation of Infarct Size (MILIS).
|
Am J Cardiol
|
1993
|
1.63
|
|
22
|
Ventricular septal and free wall rupture complicating acute myocardial infarction: experience in the Multicenter Investigation of Limitation of Infarct Size.
|
Am Heart J
|
1989
|
1.62
|
|
23
|
Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death.
|
Am J Cardiol
|
1997
|
1.61
|
|
24
|
Prior alcohol consumption and mortality following acute myocardial infarction.
|
JAMA
|
2001
|
1.61
|
|
25
|
Evaluation of precordial electrocardiographic mapping as a means of assessing changes in myocardial ischemic injury.
|
Circulation
|
1975
|
1.60
|
|
26
|
A simplified method to predict occurrence of complete heart block during acute myocardial infarction.
|
Am J Cardiol
|
1986
|
1.50
|
|
27
|
Immunohistochemical localization in rabbit brain of a peptide resembling the COOH-terminal octapeptide of cholecystokinin.
|
Proc Natl Acad Sci U S A
|
1977
|
1.46
|
|
28
|
Sudden cardiac death. Support for a role of triggering in causation.
|
Circulation
|
1993
|
1.45
|
|
29
|
The Soviet health system--aspects of relevance for medicine in the United States.
|
N Engl J Med
|
1972
|
1.43
|
|
30
|
Use of changes in the epicardial QRS complex to assess interventions which modify the extent of myocardial necrosis following coronary artery occlusion.
|
Circulation
|
1976
|
1.42
|
|
31
|
Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison.
|
Circulation
|
1984
|
1.41
|
|
32
|
Nifedipine therapy for Prinzmetal's angina.
|
Circulation
|
1978
|
1.41
|
|
33
|
Hypobetalipoproteinemia is associated with low levels of hemostatic risk factors in the Framingham offspring population.
|
Circulation
|
1997
|
1.40
|
|
34
|
Pericarditis in acute myocardial infarction: characterization and clinical significance.
|
Am Heart J
|
1989
|
1.40
|
|
35
|
Educational attainment, anger, and the risk of triggering myocardial infarction onset. The Determinants of Myocardial Infarction Onset Study Investigators.
|
Arch Intern Med
|
1997
|
1.39
|
|
36
|
Favorable effects of hyaluronidase on electrocardiographic evidence of necrosis in patients with acute myocardial infarction.
|
N Engl J Med
|
1977
|
1.38
|
|
37
|
Impact of diabetes on long-term survival after acute myocardial infarction: comparability of risk with prior myocardial infarction.
|
Diabetes Care
|
2001
|
1.37
|
|
38
|
Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham Offspring Population.
|
Circulation
|
2000
|
1.36
|
|
39
|
Implications for acute intervention related to time of hospital arrival in acute myocardial infarction.
|
Am J Cardiol
|
1986
|
1.33
|
|
40
|
Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study.
|
Arterioscler Thromb Vasc Biol
|
1999
|
1.33
|
|
41
|
Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physicians.
|
Circulation
|
1990
|
1.32
|
|
42
|
Risk factors for sudden death after acute myocardial infarction: two-year follow-up.
|
Am J Cardiol
|
1984
|
1.29
|
|
43
|
Increased onset of sudden cardiac death in the first three hours after awakening.
|
Am J Cardiol
|
1992
|
1.21
|
|
44
|
Management of sexual dysfunction in patients with cardiovascular disease: recommendations of The Princeton Consensus Panel.
|
Am J Cardiol
|
2000
|
1.20
|
|
45
|
Nifedipine and conventional therapy for unstable angina pectoris: a randomized, double-blind comparison.
|
Circulation
|
1984
|
1.18
|
|
46
|
Alcohol consumption and hemostatic factors: analysis of the Framingham Offspring cohort.
|
Circulation
|
2001
|
1.18
|
|
47
|
Precordial electrocardiographic mapping. A technique to assess the efficacy of interventions designed to limit infarct size.
|
Circulation
|
1978
|
1.16
|
|
48
|
Morning peak in ventricular tachyarrhythmias detected by time of implantable cardioverter/defibrillator therapy. The CPI Investigators.
|
Circulation
|
1995
|
1.16
|
|
49
|
Modifiers of timing and possible triggers of acute myocardial infarction in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Study Group.
|
J Am Coll Cardiol
|
1992
|
1.12
|
|
50
|
Sleep, dreams, and sudden death: the case for sleep as an autonomic stress test for the heart.
|
Cardiovasc Res
|
1996
|
1.11
|
|
51
|
A perspective on the potential problems with aspirin as an antithrombotic agent: a comparison of studies in an animal model with clinical trials.
|
J Am Coll Cardiol
|
1999
|
1.07
|
|
52
|
Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study.
|
Circulation
|
1995
|
1.05
|
|
53
|
Time of onset of symptoms of acute myocardial infarction.
|
Am J Cardiol
|
1990
|
1.02
|
|
54
|
Circadian variation in the onset of unstable angina and non-Q-wave acute myocardial infarction (the TIMI III Registry and TIMI IIIB).
|
Am J Cardiol
|
1997
|
1.02
|
|
55
|
Increased risk of congestive heart failure among infarctions with nighttime onset.
|
Am Heart J
|
2000
|
1.02
|
|
56
|
Prognostic significance of location and type of myocardial infarction: independent adverse outcome associated with anterior location.
|
J Am Coll Cardiol
|
1988
|
1.01
|
|
57
|
Sudden cardiac death, genes, and arrhythmogenesis : consideration of new population and mechanistic approaches from a national heart, lung, and blood institute workshop, part I.
|
Circulation
|
2001
|
1.01
|
|
58
|
Triggering of plaque disruption and arterial thrombosis in an atherosclerotic rabbit model.
|
Circulation
|
1995
|
1.01
|
|
59
|
Rapidity and duration of platelet suppression by enteric-coated aspirin in healthy young men.
|
Am J Cardiol
|
1992
|
1.01
|
|
60
|
Evaluation of sex-related differences in survival after hospitalization for acute myocardial infarction.
|
Am J Cardiol
|
2001
|
0.99
|
|
61
|
The in-hospital development of cardiogenic shock after myocardial infarction: incidence, predictors of occurrence, outcome and prognostic factors. The MILIS Study Group.
|
J Am Coll Cardiol
|
1989
|
0.98
|
|
62
|
Prevention of nifedipine of abnormal coronary vasoconstriction in patients with coronary artery disease.
|
Circulation
|
1981
|
0.97
|
|
63
|
Nonuniform nighttime distribution of acute cardiac events: a possible effect of sleep states.
|
Circulation
|
1997
|
0.97
|
|
64
|
Propranolol and the morning increase in the frequency of sudden cardiac death (BHAT Study).
|
Am J Cardiol
|
1989
|
0.96
|
|
65
|
High-risk subgroups of patients with non-Q wave myocardial infarction based on direction and severity of ST segment deviation.
|
Am Heart J
|
1987
|
0.95
|
|
66
|
Efforts to limit the size of myocardial infarcts.
|
Ann Intern Med
|
1981
|
0.95
|
|
67
|
Morning increase in platelet aggregability. Association with assumption of the upright posture.
|
Circulation
|
1988
|
0.94
|
|
68
|
Sudden cardiac death, genes, and arrhythmogenesis: consideration of new population and mechanistic approaches from a National Heart, Lung, and Blood Institute workshop, Part II.
|
Circulation
|
2001
|
0.93
|
|
69
|
A patent infarct-related artery is associated with reduced long-term mortality after percutaneous transluminal coronary angioplasty for postinfarction ischemia and an ejection fraction <50%.
|
Circulation
|
1996
|
0.93
|
|
70
|
The futility index. An approach to the cost-effective termination of randomized clinical trials.
|
Am J Med
|
1985
|
0.93
|
|
71
|
Prognostic significance of the Karnofsky Performance Status score in patients with acute myocardial infarction: comparison with the left ventricular ejection fraction and the exercise treadmill test performance. The MILIS Study Group.
|
Am Heart J
|
1991
|
0.92
|
|
72
|
Platelet glycoprotein IIIa Pl(a) polymorphism, fibrinogen, and platelet aggregability: The Framingham Heart Study.
|
Circulation
|
2001
|
0.92
|
|
73
|
Significance of location (anterior versus inferior) and type (Q-wave versus non-Q-wave) of acute myocardial infarction in patients undergoing percutaneous transluminal coronary angioplasty for postinfarction ischemia.
|
Am J Cardiol
|
1995
|
0.91
|
|
74
|
Triggering of sudden death--lessons from an earthquake.
|
N Engl J Med
|
1996
|
0.91
|
|
75
|
Sounding Boards. Let's not let the genie escape from the bottle--again.
|
N Engl J Med
|
1981
|
0.90
|
|
76
|
Triggering of acute myocardial infarction.
|
J Cardiovasc Risk
|
1995
|
0.90
|
|
77
|
Factor VII gene polymorphism, factor VII levels, and prevalent cardiovascular disease: the Framingham Heart Study.
|
Arterioscler Thromb Vasc Biol
|
2000
|
0.90
|
|
78
|
Lack of effect of recent alcohol consumption on the course of acute myocardial infarction.
|
Am Heart J
|
1999
|
0.89
|
|
79
|
Effect of propranolol on myocardial-infarct size in a randomized blinded multicenter trial.
|
N Engl J Med
|
1984
|
0.88
|
|
80
|
Effects of therapy with nifedipine GITS or atenolol on mental stress-induced ischemic left ventricular dysfunction.
|
J Am Coll Cardiol
|
1998
|
0.87
|
|
81
|
Sympathetic activity as the cause of the morning increase in cardiac events. A likely culprit, but the evidence remains circumstantial.
|
Circulation
|
1995
|
0.86
|
|
82
|
Suppression of silent ischemia by metoprolol without alteration of morning increase of platelet aggregability in patients with stable coronary artery disease.
|
Circulation
|
1989
|
0.85
|
|
83
|
Effects of minoxidil on coronary collateral flow and acute myocardial injury following experimental coronary artery occlusion.
|
Cardiovasc Res
|
1978
|
0.84
|
|
84
|
Efficacy of nifedipine therapy in patients with refractory angina pectoris: significance of the presence of coronary vasospasm.
|
Am Heart J
|
1983
|
0.84
|
|
85
|
Angioscopic assessment of coronary lesions underlying thrombus.
|
Am J Cardiol
|
1997
|
0.84
|
|
86
|
Prevention by nifedipine of cold pressor-induced decrease in left ventricular ejection fraction.
|
J Am Coll Cardiol
|
1983
|
0.83
|
|
87
|
Enzymatic estimation of myocardial infarct size when early creatine kinase values are not available.
|
Am J Cardiol
|
1983
|
0.83
|
|
88
|
Prognosis after cardiac arrest due to ventricular tachycardia or ventricular fibrillation associated with acute myocardial infarction (the MILIS Study). Multicenter Investigation of the Limitation of Infarct Size.
|
Am J Cardiol
|
1987
|
0.83
|
|
89
|
Upright posture and maximal exercise increase platelet aggregability and prostacyclin production in healthy male subjects.
|
Br J Sports Med
|
1999
|
0.82
|
|
90
|
Circadian variation and cardiovascular disease.
|
N Engl J Med
|
1991
|
0.82
|
|
91
|
Factors leading to shorter survival after acute myocardial infarction in patients ages 65 to 75 years compared with younger patients.
|
Am J Cardiol
|
1988
|
0.82
|
|
92
|
Sequential combination thrombolytic therapy for acute myocardial infarction: results of the Pro-Urokinase and t-PA Enhancement of Thrombolysis (PATENT) Trial.
|
J Am Coll Cardiol
|
1995
|
0.82
|
|
93
|
Therapy of coronary vasoconstriction in patients with coronary artery disease.
|
Am J Cardiol
|
1981
|
0.81
|
|
94
|
Angioscopic predictors of early adverse outcome after coronary angioplasty in patients with unstable angina and non-Q-wave myocardial infarction.
|
Circulation
|
1996
|
0.81
|
|
95
|
Height is not associated with long-term survival after acute myocardial infarction.
|
Am Heart J
|
2001
|
0.81
|
|
96
|
Use of skin conductance changes during mental stress testing as an index of autonomic arousal in cardiovascular research.
|
Am Heart J
|
1994
|
0.81
|
|
97
|
Diagnosis of myocardial infarction: historical notes from the Soviet Union and the United States.
|
Am J Cardiol
|
1977
|
0.81
|
|
98
|
Morning increase in ambulatory ischemia in patients with stable coronary artery disease. Importance of physical activity and increased cardiac demand.
|
Circulation
|
1994
|
0.81
|
|
99
|
Inappropriate coronary vasoconstriction in patients with coronary artery disease: a role for nifedipine?
|
Am J Cardiol
|
1979
|
0.81
|
|
100
|
Efficacy of nifedipine therapy for refractory angina pectoris.
|
Am Heart J
|
1982
|
0.80
|
|
101
|
Nifedipine for coronary-artery spasm after revascularization.
|
N Engl J Med
|
1982
|
0.80
|
|
102
|
Similar results of percutaneous transluminal coronary angioplasty for women and men with postmyocardial infarction ischemia.
|
J Am Coll Cardiol
|
1994
|
0.80
|
|
103
|
Continuous hypothermic arrest versus intermittent ischemia for myocardial protection during coronary revascularization.
|
Ann Thorac Surg
|
1977
|
0.80
|
|
104
|
Recent aspirin use is associated with smaller myocardial infarct size and lower likelihood of Q-wave infarction.
|
Am Heart J
|
1999
|
0.80
|
|
105
|
Effect of hyaluronidase on mortality and morbidity in patients with early peaking of plasma creatine kinase MB and non-transmural ischaemia. Multicentre investigation for the limitation of infarct size (MILIS).
|
Br Heart J
|
1988
|
0.80
|
|
106
|
Effects of nadolol on hemodynamic and hemostatic responses to potential mental and physical triggers of myocardial infarction in subjects with mild systemic hypertension.
|
Am J Cardiol
|
1993
|
0.80
|
|
107
|
The pathophysiology of the onset of morning cardiovascular events.
|
Am J Hypertens
|
1996
|
0.79
|
|
108
|
Prognostic significance of the treadmill exercise test performance 6 months after myocardial infarction.
|
J Am Coll Cardiol
|
1986
|
0.79
|
|
109
|
Management of sexual dysfunction in patients with cardiovascular disease: recommendations of the Princeton Consensus Panel.
|
Am J Cardiol
|
2000
|
0.79
|
|
110
|
Coronary artery thrombosis: historical aspects.
|
J Am Coll Cardiol
|
1983
|
0.79
|
|
111
|
Suicide attempts in an African schizophrenia population: an assessment of demographic risk factors.
|
Suicide Life Threat Behav
|
2004
|
0.79
|
|
112
|
Platelet alpha 2 adrenoceptor characteristics during the morning increase in platelet aggregability.
|
Eur Heart J
|
1992
|
0.78
|
|
113
|
The serum kinetics of bovine testicular hyaluronidase in dogs, rats and humans.
|
J Pharmacol Exp Ther
|
1982
|
0.78
|
|
114
|
Effects on platelet aggregation and fibrinolytic activity during upright posture and exercise in healthy men.
|
Am J Cardiol
|
1992
|
0.78
|
|
115
|
Prognostic implications of an early peak in plasma MB creatine kinase in patients with acute myocardial infarction.
|
J Am Coll Cardiol
|
1987
|
0.78
|
|
116
|
Intravenous bovine testicular hyaluronidase depolymerizes myocardial hyaluronic acid in dogs with coronary artery occlusion.
|
Circ Res
|
1981
|
0.78
|
|
117
|
Role of beta-adrenergic blockade in the therapy of patients with myocardial infarction.
|
Am J Med
|
1983
|
0.78
|
|
118
|
Electrocardiographic, enzymatic and scintigraphic criteria of acute myocardial infarction as determined from study of 726 patients (A MILIS Study).
|
Am J Cardiol
|
1985
|
0.78
|
|
119
|
Sudden death and its relation to QT-interval prolongation after acute myocardial infarction: two-year follow-up.
|
Am J Cardiol
|
1986
|
0.77
|
|
120
|
Insulin therapy for depressed myocardial contractility after prolonged ischemia.
|
Am J Cardiol
|
1978
|
0.77
|
|
121
|
Stress-induced hemodynamic and hemostatic changes in patients with systemic hypertension: effect of verapamil.
|
Clin Cardiol
|
1996
|
0.77
|
|
122
|
Effect of aspirin dosage and enteric coating on platelet reactivity.
|
Am J Cardiol
|
1997
|
0.77
|
|
123
|
Physical activity and the triggering of myocardial infarction: the case for regular exercise.
|
Heart
|
1996
|
0.77
|
|
124
|
The effect of enteric-coated aspirin on the morning increase in platelet activity.
|
Am Heart J
|
1991
|
0.76
|
|
125
|
Efficacy of nifedipine therapy in patients with refractory angina pectoris: significance of the presence of coronary vasospasm.
|
Arq Bras Cardiol
|
1983
|
0.76
|
|
126
|
Aspirin, platelet aggregation, and the circadian variation of acute thrombotic events.
|
Chronobiol Int
|
1991
|
0.76
|
|
127
|
Fibrinolytic potential is significantly increased by oestrogen treatment in postmenopausal women with mild dyslipidaemia.
|
Heart
|
1998
|
0.75
|
|
128
|
Mortality for women after acute myocardial infarction: MILIS Study Group.
|
Am J Cardiol
|
1989
|
0.75
|
|
129
|
Morning vs afternoon exertion. Both are safe, but which is safer?
|
Arch Intern Med
|
1993
|
0.75
|
|
130
|
Nifedipine therapy for recurrent ischemic pain following myocardial infarction.
|
Clin Cardiol
|
1982
|
0.75
|
|
131
|
Effect of diabetes mellitus and its treatment on ventricular arrhythmias complicating acute myocardial infarction.
|
Diabet Med
|
2005
|
0.75
|
|
132
|
Hemodynamic and hemostatic responses to morning and evening exertion in systemic hypertension and implications for triggering of acute cardiovascular disease.
|
Am J Cardiol
|
1994
|
0.75
|
|
133
|
Onset of acute myocardial infarction--circadian variation and triggers.
|
Cardiovasc Res
|
1992
|
0.75
|
|
134
|
Rate of disappearance of creatine kinase-MB after acute myocardial infarction: clinical determinants of variability.
|
Am Heart J
|
1988
|
0.75
|
|
135
|
Prevention and practical aspects of triggering of cardiovascular events.
|
Cardiol Clin
|
1996
|
0.75
|
|
136
|
The effect of perfluorocarbons on experimental myocardial ischemia and infarction.
|
Prog Clin Biol Res
|
1983
|
0.75
|
|
137
|
Nifedipine therapy for coronary vasospasm.
|
Arch Mal Coeur Vaiss
|
1983
|
0.75
|
|
138
|
Requirements for controlled clinical trials of preoperative cardiovascular risk reduction.
|
Control Clin Trials
|
1995
|
0.75
|
|
139
|
Nifedipine in the treatment of cardiovascular disease.
|
Pharmacotherapy
|
1986
|
0.75
|
|
140
|
Use of calcium channel blocking agents in the management of ischaemic heart disease.
|
Eur Heart J
|
1985
|
0.75
|
|
141
|
Cardiopulmonary resuscitation and the 1985 Nobel Peace Prize.
|
N Engl J Med
|
1986
|
0.75
|
|
142
|
Pathophysiology and triggers of acute myocardial infarction: clinical implications.
|
Clin Investig
|
1992
|
0.75
|
|
143
|
Effects of intravenous fluorocarbons during and without oxygen enhancement on acute myocardial ischemic injury assessed by measurement of intramyocardial gas tensions.
|
Am Heart J
|
1982
|
0.75
|
|
144
|
Effect of sustained-release Verapamil on the morning systemic arterial pressure surge during daily activity in patients with systemic hypertension.
|
Am J Cardiol
|
1997
|
0.75
|
|
145
|
Can infarct size be limited in patients with acute myocardial infarction?
|
Cardiovasc Clin
|
1983
|
0.75
|
|
146
|
Arrhythmias after infarction.
|
Ann Intern Med
|
1972
|
0.75
|
|
147
|
Heparin inhibits bovine testicular hyaluronidase activity in myocardium of dogs with coronary artery occlusion.
|
Am J Cardiol
|
1984
|
0.75
|